These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 2488233)

  • 1. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
    Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor genes.
    Levine AJ
    Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
    Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
    J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
    Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
    Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular proteins that are targetted by DNA tumor viruses for transformation.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
    Yehiely F; Oren M
    Cell Growth Differ; 1992 Nov; 3(11):803-9. PubMed ID: 1467307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
    Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
    Schmieg FI; Simmons DT
    Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
    Yam JW; Zheng JY; Hsiao WL
    Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
    Nevels M; Spruss T; Wolf H; Dobner T
    Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.